eMedicine Specialties > Pediatrics: Genetics and Metabolic Disease > Genetics

Proteus Syndrome

Author: Beth A Pletcher, MD, Associate Professor, Co-Director of The Neurofibromatosis Center of New Jersey, Department of Pediatrics, University of Medicine and Dentistry of New Jersey
Contributor Information and Disclosures

Updated: Mar 18, 2010

Introduction

Background

Proteus syndrome is a rare condition that can be loosely categorized as a hamartomatous disorder. It is a complex disorder with multisystem involvement and great clinical variability. Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man" and studied by Treves in the 1800s) is now, in retrospect, thought by clinical experts to actually have had Proteus syndrome.1

This condition is characterized by various cutaneous and subcutaneous lesions, including vascular malformations, lipomas, hyperpigmentation, and several types of nevi. Partial gigantism with limb or digital overgrowth is pathognomonic, with an unusual body habitus and, often, cerebriform thickening of the soles of the feet. Because cutaneous lesions tend to appear over time, the diagnosis may be delayed until late infancy, childhood, or even adulthood. Orthopedic complications often pose the most challenging medical problems, although vascular complications also contribute to overall morbidity. Severe disfigurement and social stigmatization are additional challenges that must be addressed.1

Examples of various malformations and physical symptoms in Proteus syndrome are shown in the images below.

Macroglossia and hemifacial overgrowth associated...

Macroglossia and hemifacial overgrowth associated with hyperpigmentation.

Macroglossia and hemifacial overgrowth associated...

Macroglossia and hemifacial overgrowth associated with hyperpigmentation.


Port wine stain on the trunk with small epidermal...

Port wine stain on the trunk with small epidermal nevus.

Port wine stain on the trunk with small epidermal...

Port wine stain on the trunk with small epidermal nevus.


Macrodactyly with splaying of toes after toe redu...

Macrodactyly with splaying of toes after toe reduction procedure.

Macrodactyly with splaying of toes after toe redu...

Macrodactyly with splaying of toes after toe reduction procedure.


Ear enlargement associated with cutaneous hyperpi...

Ear enlargement associated with cutaneous hyperpigmentation and hemifacial macrosomia.

Ear enlargement associated with cutaneous hyperpi...

Ear enlargement associated with cutaneous hyperpigmentation and hemifacial macrosomia.


Scoliosis with scar resulting from prior surgical...

Scoliosis with scar resulting from prior surgical resection of a large subcutaneous lipoma.

Scoliosis with scar resulting from prior surgical...

Scoliosis with scar resulting from prior surgical resection of a large subcutaneous lipoma.


Evidence of proximal muscle wasting of the upper ...

Evidence of proximal muscle wasting of the upper extremities.

Evidence of proximal muscle wasting of the upper ...

Evidence of proximal muscle wasting of the upper extremities.


Hypertrophy of the thighs and calves.

Hypertrophy of the thighs and calves.

Hypertrophy of the thighs and calves.

Hypertrophy of the thighs and calves.


Profile demonstrating retrognathia.

Profile demonstrating retrognathia.

Profile demonstrating retrognathia.

Profile demonstrating retrognathia.


Pathophysiology

Manifestations probably result from somatic mosaicism for a dominant lethal gene, but the gene locus has yet to be identified. Because hyperplasia and hypoplasia often occur together, another hypothesis suggests that the postzygotic event that results in these clinical manifestations is embryonic somatic recombination leading to at least 3 subsets of cells. These subsets include normal, overgrowth (pleioproteus), and atrophy (elattoproteus) cells. Reports of discordance for Proteus syndrome in monozygotic twins supports the theory that the condition arises postzygotically.2

Frequency

International

Proteus syndrome is believed to be exceedingly rare, with less than 100 confirmed affected individuals reported worldwide.3 This suggests that prevalence is less than 1 case per 1,000,000 live births.

Mortality/Morbidity

The following is noted in patients with Proteus syndrome:

  • Hemihyperplasia (asymmetric overgrowth of the head, face, and digits) and soft tissue overgrowth are among the more significant medical complications. Lesions are identified at birth in more than 17% of patients.4 Some scientists have suggested that the bony overgrowth in Proteus syndrome is secondary to mesenchymal changes beginning during embryonic life, with formation of extra-large cartilage precursors.5
  • Soft tissue and bone overgrowth may slow after puberty.1
  • Absent or decreased subcutaneous fat (lipohypoplasia) of the trunk or limbs may also be seen in patients with Proteus syndrome, contributing to the gracile appearance and well-recognized body habitus in severely affected individuals.6
  • Facial involvement may be associated with not only asymmetric mandibular growth, maxillary growth, or both, but also with premature dental eruption and idiopathic root resorption.
  • Eye findings may include strabismus as well as epibulbar dermoids or cysts; ocular findings are reported in more than 40% of affected individuals.4
  • Scoliosis or kyphoscoliosis may be severe and progressive, leading to respiratory compromise in some cases. Neck and trunk elongation with upper body wasting and leg muscle hypertrophy may contribute to overall abnormal body habitus and concomitant functional abnormalities.
  • Although less common, kidney or bladder problems may be identified in slightly less than 10% of affected individuals. Genitourinary problems described include hydronephrosis, renal cysts, asymmetry of the kidneys or bladder, and nephrogenic diabetes.4
  • Cutaneous and subcutaneous lesions can create significant cosmetic and functional problems. Benign growths, such as lipomas, connective tissue nevi, epidermal nevi, and vascular malformations, may be locally invasive and contribute greatly to morbidity.
  • Individuals with a larger number of skin manifestations are also more likely to have more severe involvement of other tissues.
  • Whereas ovarian cystadenomas are frequent enough in women with Proteus syndrome to be included as part of the diagnostic criteria, other fairly rare neoplasms have been identified in affected individuals. Meningiomas, various testicular tumors, and parotid monomorphic adenomas have been described.3 More recently, a patient with Proteus syndrome was shown to have multiple spinal cord meningiomas.7
  • Cystic lung malformations are reported in slightly less than 10% of patients and are especially common in younger female patients.4
  • Intrathoracic or intra-abdominal lipomas occur and should be screened for because of the particularly aggressive nature of these lesions.3,8
  • Increased risk for thrombotic events such as deep vein thrombosis (DVT) or pulmonary embolism (PE) contribute to the overall morbidity and mortality, even in young children, and is reported to be one of the most common causes of death in affected individuals.9
  • Learning disabilities or mental retardation occurs in a subset of patients. A particular facial phenotype often is associated with mental impairment with or without CNS malformations and seizures. Infantile seizures, specifically Ohtahara syndrome, have been described in several patients with Proteus syndrome in association with hemimegalencephaly.10

Race

No racial or ethnic differences in disease occurrence are apparent.

Sex

Males are almost twice as likely to be affected as females and also appear to be at greater risk for thrombosis than females.4

Age

The genetic change or somatic event leading to this syndrome is likely to present shortly after conception and is propagated in one or more subsets of embryonic cells. Even so, the diagnosis may not be suspected in many individuals until later infancy or early childhood, depending on the degree of overgrowth or rate of cutaneous lesion appearance. A fetus was prenatally identified with ultrasound findings of a large right-sided mass and unusual hand configuration. However, in this case, the actual diagnosis was not made until postmortem examination.

Clinical

History

In cases of suspected Proteus syndrome, clinicians must carefully use the standard diagnostic criteria (as listed below) to preclude misdiagnosis. A literature review suggests that less than half of reported cases have clearly defined Proteus syndrome.4  This has led to speculation that a subset of patients with presumed Proteus syndrome have PTEN gene mutations, when, in fact, these individuals do not have enough diagnostic features warrant a diagnosis of Proteus syndrome.3 The following are the 3 general criteria necessary for clinical diagnosis without regard to specific clinical features:

  • Lesions follow a mosaic distribution or pattern.
  • Problems follow a progressive course.
  • The disorder appears to be sporadic (ie, not inherited).

Diagnostic confirmation also requires the presence of manifestations listed under the following categories:

  • Category A (1 required) - Connective tissue nevus
  • Category B (2 required)
    • Epidermal nevus
    • Disproportionate overgrowth of one or more of the following: limbs, digits, cranium, vertebrae, external auditory meatus, spleen, or thymus
    • Bilateral ovarian cystadenomas or a parotid monomorphic adenoma in a patient younger than 20 years
  • Category C (all 3 required)
    • Lipomas or focal atrophy of adipose tissue
    • Capillary, venous, or lymphatic malformation
    • Facial features including dolichocephaly, a long face, down-slanting palpebrae, ptosis, depressed nasal bridge, anteverted nares, and open mouth position while at rest

Physical

  • When present at birth, asymmetric limb, digital, or cranial overgrowth may be a major diagnostic finding.
  • Digital, limb, or cranial overgrowth usually involves both soft tissue and bone.
  • Cranial or external auditory canal hyperostosis may be seen.
  • Scoliosis associated with disproportionate vertebral growth is common.
  • The combination of disproportionate overgrowth and focal atrophy can lead to a unique habitus characterized by wasting of upper arm muscles, an elongated thorax, an extremely gracile neck, and muscular hypertrophy of the thighs.
  • Cystic lung malformations that lead to cystic pulmonary emphysema and restrictive lung disease secondary to severe scoliosis are relatively common. Recurrent pneumonias, shortness of breath, or reduced exercise tolerance may point to significant respiratory compromise.
  • Organomegaly is less common but can also occur with splenomegaly or occasional thymus enlargement.
  • The 6 most common skin findings include (from most to least frequent) lipomas, vascular malformations, connective tissue nevi, epidermal nevi, partial lipohypoplasia, and patchy dermal hypoplasia.
    • Connective tissue nevi are virtually pathognomonic and typically have a cerebriform contour. They often occur on the soles of the feet but can also be found on other areas.
    • Epidermal nevi tend to be the flat, soft variety.
    • Lipomas may be well demarcated or locally invasive with large intra-abdominal or intrathoracic lesions presenting serious medical concerns.
    • Vascular lesions may include capillaries, lymphatics, venules, or combinations of these. They tend to grow gradually over time and, unlike the more common capillary hemangiomas seen in the general population, rarely regress. Port wine stains or patchy hyperpigmentation may also be seen.
  • Learning difficulties or mental retardation are seen in about 1 in 5 individuals with Proteus syndrome.
  • Facial features that often coincide with poor mental development include a prominent occiput, ptosis with or without down-slanting palpebrae, upturned nose, and a long, narrow face.
  • Seizures are reported in more than 10% of affected individuals.

More on Proteus Syndrome

Overview: Proteus Syndrome
Differential Diagnoses & Workup: Proteus Syndrome
Treatment & Medication: Proteus Syndrome
Follow-up: Proteus Syndrome
Multimedia: Proteus Syndrome
References

References

  1. Cohen MM Jr. "Proteus syndrome". In: Cohen MM Jr., Neri G, Weksberg R eds. Overgrowth Syndromes, Chapter 9. 170(6 Pt 1). New York: Oxford University Press; 2002:pp75-110.

  2. Brockmann K, Happle R, Oeffner F, König A. Monozygotic twins discordant for Proteus syndrome. Am J Med Genet A. Aug 15 2008;146A(16):2122-5. [Medline].

  3. Cohen MM Jr. Proteus syndrome: an update. Am J Med Genet C Semin Med Genet. Aug 15 2005;137C(1):38-52. [Medline].

  4. Turner JT, Cohen MM Jr, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A. Oct 1 2004;130A(2):111-22. [Medline].

  5. Pazzaglia UE, Beluffi G, Bonaspetti G, et al. Bone malformations in Proteus syndrome: an analysis of bone structural changes and their evolution during growth. Pediatr Radiol. Aug 2007;37(8):829-35. [Medline].

  6. Happle R. Lipomatosis and partial lipohypoplasia in Proteus syndrome: a clinical clue for twin spotting?. Am J Med Genet. Apr 10 1995;56(3):332-3. [Medline].

  7. Asahina A, Fujita H, Omori T, Kai H, Yamamoto M, Mii K. Proteus syndrome complicated by multiple spinal meningiomas. Clin Exp Dermatol. Nov 2008;33(6):729-32. [Medline].

  8. Furquim I, Honjo R, Bae R, Andrade W, Santos M, Tannuri U. Proteus syndrome: report of a case with recurrent abdominal lipomatosis. J Pediatr Surg. Apr 2009;44(4):E1-3. [Medline].

  9. Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet. Nov 2006;14(11):1151-7. [Medline].

  10. Bastos H, da Silva PF, de Albuquerque MA, Mattos A, Riesgo RS, Ohlweiler L. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: report of two cases. Seizure. Jun 2008;17(4):378-82. [Medline].

  11. Elsayes KM, Menias CO, Dillman JR, et al. Vascular malformation and hemangiomatosis syndromes: spectrum of imaging manifestations. AJR Am J Roentgenol. May 2008;190(5):1291-9. [Medline].

  12. Irion KL, Hocchegger B, Marchiori E, et al. Proteus syndrome: high-resolution CT and CT pulmonary densitovolumetry findings. J Thorac Imaging. Feb 2009;24(1):45-8. [Medline].

  13. Hoey SE, Eastwood D, Monsell F, Kangesu L, Harper JI, Sebire NJ. Histopathological features of Proteus syndrome. Clin Exp Dermatol. May 2008;33(3):234-8. [Medline].

  14. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg. Dec 2007;26(4):221-30. [Medline].

  15. Buis J, Enjolras O, Soupre V, Roman S, Vazquez MP, Picard A. 980-nm laser diode and treatment of subcutaneous mass in Proteus-like syndrome. J Eur Acad Dermatol Venereol. Jan 2010;24(1):109-11. [Medline].

  16. Turner J, Biesecker B, Leib J, et al. Parenting children with Proteus syndrome: experiences with, and adaptation to, courtesy stigma. Am J Med Genet A. Sep 15 2007;143A(18):2089-97. [Medline].

  17. Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet. Jun 11 1999;84(5):389-95. [Medline].

  18. Becktor KB, Becktor JP, Karnes PS, Keller EE. Craniofacial and dental manifestations of Proteus syndrome: a case report. Cleft Palate Craniofac J. Mar 2002;39(2):233-45. [Medline].

  19. Biesecker LG, Peters KF, Darling TN, et al. Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia. Am J Med Genet. Oct 2 1998;79(4):311-8. [Medline].

  20. Cohen MM Jr. Further diagnostic thoughts about the Elephant Man. Am J Med Genet. Apr 1988;29(4):777-82. [Medline].

  21. Cohen MM Jr. Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes. Am J Med Genet C Semin Med Genet. Feb 15 2003;117C(1):49-56. [Medline].

  22. Franc-Guimond J, Houle AM, Barrieras D. The Proteus syndrome associated with life threatening hematuria. J Urol. Dec 2003;170(6 Pt 1):2418-9. [Medline].

  23. Goodship J, Redfearn A, Milligan D, et al. Transmission of Proteus syndrome from father to son?. J Med Genet. Nov 1991;28(11):781-5. [Medline].

  24. Hamm H. Cutaneous mosaicism of lethal mutations. Am J Med Genet. Aug 6 1999;85(4):342-5. [Medline].

  25. Happle R. Elattoproteus syndrome: delineation of an inverse form of Proteus syndrome. Am J Med Genet. May 7 1999;84(1):25-8. [Medline].

  26. Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol. Apr 1987;16(4):899-906. [Medline].

  27. Hoeger PH, Martinez A, Maerker J, et al. Vascular anomalies in Proteus syndrome. Clin Exp Dermatol. May 2004;29(3):222-30. [Medline].

  28. Krüger G, Pelz L, Wiedemann HR. Transmission of Proteus syndrome from mother to son?. Am J Med Genet. Jan 1 1993;45(1):117-8. [Medline].

  29. Nazzaro V, Cambiaghi S, Montagnani A, et al. Proteus syndrome. Ultrastructural study of linear verrucous and depigmented nevi. J Am Acad Dermatol. Aug 1991;25(2 Pt 2):377-83. [Medline].

  30. Nguyen D, Turner JT, Olsen C, et al. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity. Arch Dermatol. Aug 2004;140(8):947-53. [Medline].

  31. Plötz SG, Abeck D, Plotz W, et al. Proteus syndrome with widespread portwine stain naevus. Br J Dermatol. Dec 1998;139(6):1060-3. [Medline].

  32. Sigaudy S, Fredouille C, Gambarelli D, et al. Prenatal ultrasonographic findings in Proteus syndrome. Prenat Diagn. Oct 1998;18(10):1091-4. [Medline].

  33. Twede JV, Turner JT, Biesecker LG, et al. Evolution of skin lesions in Proteus syndrome. J Am Acad Dermatol. May 2005;52(5):834-8. [Medline].

  34. Wiedemann HR, Burgio GR, Aldenhoff P, et al. The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr. Mar 1983;140(1):5-12. [Medline].

Further Reading

Keywords

Proteus syndrome, pleioproteus syndrome, elephant man disease, gigantism, hamartomatous disorder, vascular malformations, hyperpigmentation, scoliosis, hydronephrosis, renal cysts, pulmonary embolism, learning disability, mental retardation, treatment, symptoms

Contributor Information and Disclosures

Author

Beth A Pletcher, MD, Associate Professor, Co-Director of The Neurofibromatosis Center of New Jersey, Department of Pediatrics, University of Medicine and Dentistry of New Jersey
Beth A Pletcher, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics, American Medical Association, and American Society of Human Genetics
Disclosure: Nothing to disclose.

Medical Editor

Elaine H Zackai, MD, Professor of Pediatrics, Professor of Obstetrics and Gynecology, Professor of Pediatrics in Human Genetics, University of Pennsylvania School of Medicine; Director, Clinical Genetics Center, University of Pennsylvania; Senior Physician and Director of Clinical Genetics, The Children's Hospital of Philadelphia
Elaine H Zackai, MD is a member of the following medical societies: American Cleft Palate/Craniofacial Association, American College of Medical Genetics, and American Society of Human Genetics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Robert Anthony Saul, MD, Clinical Professor, Department of Pediatrics, University of South Carolina; Senior Clinical Geneticist, Greenwood Genetic Center
Robert Anthony Saul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics, and American College of Physician Executives
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Bruce Buehler, MD, Professor, Department of Pediatrics and Genetics, Director RSA, University of Nebraska Medical Center
Bruce Buehler, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, American Association on Mental Retardation, American College of Medical Genetics, American College of Physician Executives, American Medical Association, and Nebraska Medical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.